Related Experiment Video
Updated: Jul 30, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Childhood Pneumonia: What's Unchanged, and What's New?
Krishna Kumar Yadav1, Shally Awasthi2
1Department of Pediatrics, Dr R.M.L. Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Insights
Childhood pneumonia remains a major global health issue, particularly in India. Early detection and prompt treatment of hypoxia are crucial for preventing severe outcomes in children with pneumonia.
Area of Science:
- Pediatrics
- Public Health
- Infectious Diseases
Background:
- Childhood pneumonia is a leading cause of mortality in children under five, with India bearing the highest burden.
- Viral infections, especially respiratory syncytial virus, are increasingly recognized as significant etiologies.
- Key risk factors include malnutrition, indoor pollution, and inadequate vaccination coverage.
Purpose of the Study:
- To review the current understanding of childhood pneumonia, including etiologies, risk factors, diagnostic methods, and management strategies.
- To highlight the role of emerging diagnostic tools and biomarkers.
- To emphasize the importance of early hypoxia detection and mortality risk assessment.
Main Methods:
- Literature review of recent studies on childhood pneumonia.
- Discussion of diagnostic modalities such as lung ultrasound and biomarkers like procalcitonin.
- Analysis of risk factors and mortality assessment tools.
Main Results:
- Viruses, particularly respiratory syncytial virus, are major causes of childhood pneumonia.
- Lung ultrasound is gaining prominence in diagnosis, complementing traditional methods.
- Procalcitonin aids in guiding antibiotic duration, and pulse oximetry is vital for hypoxia management.
- The PREPARE score shows promise for mortality risk assessment.
Conclusions:
- Integrated approaches combining updated diagnostics and risk assessment are essential for managing childhood pneumonia.
- Further validation of novel biomarkers and mortality prediction tools is needed.
- Addressing risk factors and ensuring prompt, accurate treatment are critical for reducing childhood pneumonia deaths.
Abstract:
Childhood pneumonia is still a significant clinical and public health problem. India contributes the highest number of deaths due to pneumonia, accounts for about 20% of global mortality among under five children. Various etiologic agents including bacteria, viruses and atypical organism are responsible for childhood pneumonia. Recent studies suggest that viruses are one of the major causes of childhood pneumonia. Among viruses, respiratory syncytial virus has got great attention and several recent studies are reporting it as an important organism for pneumonia. Lack of exclusive breast feeding during first six months, improper timing of start and content of complimentary feeding, anemia, undernutrition, indoor pollution due to tobacco smoking and use of coal and wood for cooking food and lack of vaccinations are important risk factors. X-ray chest is not routinely performed to diagnose pneumonia while use of lung ultrasound is increasing to detect consolidation, pleural effusion, pneumothorax and pulmonary edema (interstitial syndrome). Role of C-reactive protein (CRP) and procalcitonin is similar, to differentiate between viral and bacterial pneumonia, however duration of antibiotics is better guided by procalcitonin. Newer biomarkers like IL-6, presepsin and triggering receptor expressed on myeloid cells 1 are needed to be evaluated for their use in children. Hypoxia is significantly associated with childhood pneumonia. Therefore, use of pulse oximetry should be encouraged for early detection and prompt treatment of hypoxia to prevent adverse outcomes. Among the available tools for risk of mortality assessment in children due to pneumonia, PREPARE score is the best but external validation will be needed.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:17Pulmonary Cycle: Exhalation